Coeptis Therapeutics Holdings Inc
COEPW0.012USD
-0.001-5.60%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of Coeptis Therapeutics Holdings Inc Company
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio is highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen CAR technology licensed from the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and medical researchers at the Karolinska Institute. Its NexGenAI Affiliates Network platform offers AI-powered marketing software and advanced robotic process automation capabilities. Its Coeptis Technologies division is focused on diversifying and enhancing its growth potential. Its subsidiaries include Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc.
Coeptis Therapeutics Holdings Inc Info
Ticker SymbolCOEPW
Company nameCoeptis Therapeutics Holdings Inc
IPO dateDec 17, 2020
CEO- -
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address105 Bradford Road, Suite 420
CityWEXFORD
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code15090
Phone17249346467
Websitehttps://coeptistx.com/
Ticker SymbolCOEPW
IPO dateDec 17, 2020
CEO- -
Company Executives of Coeptis Therapeutics Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Mr. David Mehalick
Mr. David Mehalick
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Ms. Christine Sheehy
Ms. Christine Sheehy
Vice President - Compliance, Secretary
Vice President - Compliance, Secretary
--
--
Mr. Christopher Calise
Mr. Christopher Calise
Independent Director
Independent Director
--
--
Mr. Christopher Cochran
Mr. Christopher Cochran
Independent Director
Independent Director
--
--
Mr. Philippe Deschamps
Mr. Philippe Deschamps
Independent Director
Independent Director
--
--
Dr. Tara Maria Desilva, Ph.D.
Dr. Tara Maria Desilva, Ph.D.
Independent Director
Independent Director
--
--
Mr. Brian Cogley
Mr. Brian Cogley
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Daniel (Dan) Yerace
Mr. Daniel (Dan) Yerace
Vice President - Operations, Director
Vice President - Operations, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. David Mehalick
Mr. David Mehalick
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Ms. Christine Sheehy
Ms. Christine Sheehy
Vice President - Compliance, Secretary
Vice President - Compliance, Secretary
--
--
Mr. Christopher Calise
Mr. Christopher Calise
Independent Director
Independent Director
--
--
Mr. Christopher Cochran
Mr. Christopher Cochran
Independent Director
Independent Director
--
--
Mr. Philippe Deschamps
Mr. Philippe Deschamps
Independent Director
Independent Director
--
--
Dr. Tara Maria Desilva, Ph.D.
Dr. Tara Maria Desilva, Ph.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Fri, Jan 2
Updated: Fri, Jan 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
25
552.87K
0.00%
--
2025Q3
26
552.87K
0.00%
-365.33K
2025Q2
27
918.20K
0.00%
+87.22K
2025Q1
26
830.98K
0.00%
-1.05M
2024Q4
29
1.01M
0.00%
-777.05K
2024Q3
33
1.78M
0.00%
-287.47K
2024Q2
34
2.07M
0.00%
-43.79K
2024Q1
34
2.12M
0.00%
-666.88K
2023Q4
33
1.49M
0.00%
-10.15K
2023Q3
31
1.50M
0.00%
-491.82K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Clear Street LLC
200.00
0%
+200.00
--
Jun 30, 2025
Clear Street Group Inc
4.99K
0%
+4.99K
--
Sep 30, 2025
IONIC Capital Management, L.L.C.
--
0%
-93.56K
-100.00%
Dec 31, 2024
TD Securities, Inc.
44.84K
0%
-118.00
-0.26%
Sep 30, 2025
HRT Financial LP
--
0%
-100.11K
-100.00%
Sep 30, 2024
Susquehanna International Group, LLP
--
0%
-54.68K
-100.00%
Sep 30, 2025
Meteora Capital LLC
114.87K
0%
-135.13K
-54.05%
Sep 30, 2025
RiverNorth Capital Management LLC
147.97K
0%
-1.93K
-1.29%
Sep 30, 2025
Walleye Trading, LLC
79.94K
0%
-50.23K
-38.59%
Sep 30, 2025
Skyview Investment Advisors, LLC
55.12K
0%
--
--
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
